Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 3/20 | 0.33 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | PTAFR | P25105 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5929168 | 0.88 | KMT2A (0.39) | UTS2RLMNASMN1; SMN2HCRTR1HCRTR2 | |
| SCHEMBL5929165 | 0.80 | UTS2R (0.34) | UTS2RLMNASMN1; SMN2KMT2AALDH1A1 | |
| SCHEMBL5929326 | 0.80 | KDM4E (0.44) | LMNASMN1; SMN2HCRTR1HCRTR2KMT2A | |
| SCHEMBL5928930 | 0.78 | KDM4E (0.39) | LMNASMN1; SMN2HCRTR1HCRTR2KMT2A | |
| SCHEMBL5929006 | 0.78 | IL33 (0.41) | LMNAKMT2AMAOBMAOAALDH1A1 | |
| SCHEMBL5929254 | 0.77 | KDM4E (0.42) | LMNASMN1; SMN2HCRTR1HCRTR2KMT2A | |
| SCHEMBL5929107 | 0.75 | KDM4E (0.39) | LMNAKMT2AALDH1A1POLBKDM4E | |
| SCHEMBL5929230 | 0.75 | POLB (0.39) | LMNAKMT2AALDH1A1POLBKDM4E | |
| SCHEMBL5928975 | 0.71 | CNR1 (0.37) | LMNASMN1; SMN2KMT2APOLBKDM4E | |
| SCHEMBL5929150 | 0.70 | KDM4E (0.50) | SMN1; SMN2KMT2AALDH1A1POLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060154917-A1 | Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators | NEUROGEN CORPORATION (US) | 2006-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060154917-A1 | Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators | C5AR1, C5AR2, C3AR1 | UTS2R 149/4885LMNA 4776/4885SMN1; SMN2 4708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.